Yizhi Xingnao prescription improves the cognitive function of patients after a transient ischemic attack

作     者：Donglin Jiang Xing Chu Lingling Hu Shengyang Jiang Feng Hu Junming Sun Chengwan Li 

作者机构：The Third Affiliated Hospital of Nantong University Wuxi 214000 Jiangsu Province China 

出 版 物：《Neural Regeneration Research》 (中国神经再生研究（英文版）)

年 卷 期：2012年第7卷第6期

页      面：434-439页

核心收录：

学科分类：0710[理学-生物学] 07[理学] 071009[理学-细胞生物学] 09[农学] 071006[理学-神经生物学] 0901[农学-作物学] 090102[农学-作物遗传育种] 

基　　金：sponsored by Jiangsu Provincial Administration of Traditional Chinese Medicine  No. LB09090 

主　　题：Yizhi Xingnao prescription transient ischemic attack mild cognitive impairment Montreal Cognitive Assessment Scale ergoloid mesylates aspirin 

摘      要：Patients with mild cognitive impairment after a transient ischemic attack were included in this study. They were treated with Yizhi Xingnao prescription, ergoloid mesylates or aspirin for 60 days. Evaluation using the Montreal Cognitive Assessment Scale showed that cognitive function was significantly improved in all patients, especially after the combined treatment of Yizhi Xingnao and aspirin. The scores from the Montreal Cognitive Assessment Scale were improved overall and the effective treatment rate was as high as 79%, which was higher than patients treated with a combination of ergoloid mesylates and aspirin, or aspirin alone. Our experimental findings indicate that YizhiXingnao prescription can improve mild cognitive impairment after a transient ischemic attack, and that it is more effective than ergoloid mesylates.